2 completed, 2 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 2 |
Follow OSU 6162: new trials by email Literature Review of OSU 6162 trials Research Report on OSU 6162
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OSU6162 as add-on in SSRI/SNRI-resistant Depression OSU6162, Placebo - Depression, Depressive Disorder, Treatment-Resistant | Phase 2 | Recruiting | Göteborg University | 180 | 2022-04-21 | 2026-09-15 |
| OSU6162 in Bipolar Depression (OBID) OSU6162 - Bipolar Depression | Phase 2 | Recruiting | Göteborg University | 22 | 2021-10-25 | 2026-09-15 |
| Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage OSU 6162, Placebo Oral Tablet - Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Completed | Oslo University Hospital | 100 | 2017-09-05 | 2019-11-22 |
| Study Evaluating Efficacy and Safety of OSU6162 in the Treatment of Residual Symptoms After Stroke OSU 6162, Placebo oral tablet - Stroke Sequelae | Phase 2 | Completed | Arvid Carlsson Research AB | 101 | 2017-03-20 | 2020-10-01 |
Mental Fatigue (2) · Bipolar Disorder (1) · Depression (1) · Depressive Disorder (1) · Depressive Disorder, Treatment-Resistant (1) · Stroke (1) · Subarachnoid Hemorrhage (1)
Göteborg University (2) · Arvid Carlsson Research AB (1) · Oslo University Hospital (1)
Sweden (3) · Norway (1)
Angelika Sorteberg, MD (1) · Carl-Gerhard Gottfries, Prof. (1) · Elias Eriksson, Professor (1)
2016 (1)